Cost-Effectiveness of Early Treatment With Originator Biologics or Their Biosimilars After Methotrexate Failure in Patients With Established Rheumatoid Arthritis

Advances in Therapy - United States
doi 10.1007/s12325-019-00986-7
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Efficacy of Tofacitinib Monotherapy in Methotrexate-Naive Patients With Early or Established Rheumatoid Arthritis

RMD Open
RheumatologyAllergyImmunology
2016English

Effectiveness of Subcutaneously Administered Methotrexate in Patients With Rheumatoid Arthritis

Advances in Clinical and Experimental Medicine
BiochemistryMedicineGeneticsMolecular Biology
2019English

Achieving Comprehensive Disease Control in Patients With Early and Established Rheumatoid Arthritis Treated With Adalimumab Plus Methotrexate Versus Methotrexate Alone

RMD Open
RheumatologyAllergyImmunology
2017English

Pms56 - Cost-Effectiveness Analysis of Subcutaneous Tocilizumab Without Methotrexate in Rheumatoid Arthritis Treatment

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Pms44 - Cost-Effectiveness Analysis of Subcutaneous Tocilizumab Plus Methotrexate in Rheumatoid Arthritis Treatment

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

The Cost-Effectiveness of Biologics for the Treatment of Rheumatoid Arthritis: A Systematic Review

PLoS ONE
Multidisciplinary
2015English

Therapies for Active Rheumatoid Arthritis After Methotrexate Failure

Rheumatology: Current Research
2017English

Effectiveness of TNF Inhibitor Treatment With Various Methotrexate Doses in Patients With Rheumatoid Arthritis: Results From Clinical Practice

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
2014English

Impact of Plan-Level Access Restrictions on Effectiveness of Biologics Among Patients With Rheumatoid or Psoriatic Arthritis

PharmacoEconomics - Open
Health PolicyPharmacology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy